Vascular endothelial growth factor-loaded injectable hydrogel enhances plasticity in the injured spinal cord

Journal of Biomedical Materials Research - Part A

Volumn 102, Issue 7, 2014, Pages 2345-2355

  Des Rieux, Anne ^a   De Berdt, Pauline ^a   Ansorena, Eduardo ^a,b   Ucakar, Bernard ^a   Damien, Jacobs ^a   Schakman, Olivier ^a   Audouard, Emilie ^a   Bouzin, Caroline ^a   Auhl, Dietmar ^a   Simõn Yarza, Teresa ^b   Feron, Olivier ^a   Blanco Prieto, Maria J ^b   Carmeliet, Peter ^c   Bailly, Christian ^a   Clotman, Fréderic ^a   Préat, Véronique ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b UNIVERSITY OF NAVARRA   (Spain)

^c DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

alginate; injectable hydrogel; microparticles; nanoparticles; spinal cord; VEGF delivery

Indexed keywords

ALGINATE; CELL PROLIFERATION; ENDOTHELIAL CELLS; NANOPARTICLES; PLASTICITY;

INJECTABLE HYDROGELS; INJURED SPINAL CORDS; MICRO-PARTICLES; RAT SPINAL CORD; SPINAL CORDS; VASCULAR ENDOTHELIAL GROWTH; VASCULAR ENDOTHELIAL GROWTH FACTOR; VEGF DELIVERY;

HYDROGELS;

ALGINIC ACID; FIBRINOGEN; MICROSPHERE; NANOPARTICLE; VASCULOTROPIN; BIOMATERIAL; HYDROGEL; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EX VIVO STUDY; HYDROGEL; MOUSE; NERVE CELL PLASTICITY; NERVE FIBER GROWTH; NONHUMAN; PROTEIN SECRETION; SPINAL CORD INJURY; SPINAL CORD REGENERATION; TREATMENT OUTCOME; 3T3 CELL LINE; ANIMAL; PATHOPHYSIOLOGY; RAT;

ANIMALS; BIOCOMPATIBLE MATERIALS; HYDROGELS; MICE; NEURONAL PLASTICITY; NIH 3T3 CELLS; RATS; SPINAL CORD INJURIES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84901505907     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34915     Document Type: Article

References (52)

1. Slaughter BV, Khurshid SS, Fisher OZ, Khademhosseini A, Peppas NA,. Hydrogels in regenerative medicine. Adv Mater 2009; 21: 3307-3329.
2. Wu J, Zeng F, Huang XP, Chung JC, Konecny F, Weisel RD, Li RK. Infarct stabilization and cardiac repair with a VEGF-conjugated, injectable hydrogel. Biomaterials 2011; 32: 579-586.
3. Zhao L, Weir MD, Xu HH,. An injectable calcium phosphate-alginate hydrogel-umbilical cord mesenchymal stem cell paste for bone tissue engineering. Biomaterials 2010; 31: 6502-6510.
4. Gilbert RJ, Rivet CJ, Zuidema JM, Popovich PG,. Biomaterial design considerations for repairing the injured spinal cord. Crit Rev Biomed Eng 2011; 39: 125-180.
5. Cho Y, Borgens RB,. Polymer and nano-technology applications for repair and reconstruction of the central nervous system. Exp Neurol 2012; 233: 126-144.
6. Rossi F, Perale G, Papa S, Forloni G, Veglianese P,. Current options for drug delivery to the spinal cord. Expert Opin Drug Deliv 2013; 10: 385-396.
7. Prang P, Muller R, Eljaouhari A, Heckmann K, Kunz W, Weber T, Faber C, Vroemen M, Bogdahn U, Weidner N. The promotion of oriented axonal regrowth in the injured spinal cord by alginate-based anisotropic capillary hydrogels. Biomaterials 2006; 27: 3560-3569.
8. Tobias CA, Han SS, Shumsky JS, Kim D, Tumolo M, Dhoot NO, Wheatley MA, Fischer I, Tessler A, Murray M. Alginate encapsulated BDNF-producing fibroblast grafts permit recovery of function after spinal cord injury in the absence of immune suppression. J Neurotrauma 2005; 22: 138-156.
9. Kataoka K, Suzuki Y, Kitada M, Hashimoto T, Chou H, Bai H, Ohta M, Wu S, Suzuki K, Ide C. Alginate enhances elongation of early regenerating axons in spinal cord of young rats. Tissue Eng 2004; 10: 493-504.
10. Tobias CA, Dhoot NO, Wheatley MA, Tessler A, Murray M, Fischer I,. Grafting of encapsulated BDNF-producing fibroblasts into the injured spinal cord without immune suppression in adult rats. J Neurotrauma 2001; 18: 287-301.
11. Tan R, Niu X, Gan S, Feng Q,. Preparation and characterization of an injectable composite. J Mater Sci Mater Med 2009; 20: 1245-1253.
12. Erdogan B, Bavbek M, Sahin IF, Caner H, Ozen O, Denkbas EB, Altinors MN. Fetal allogeneic umbilical cord cell transplantation improves motor function in spinal cord-injured rats. Turk Neurosurg 2010; 20: 286-294.
13. Suehiro K, Mizuguchi J, Nishiyama K, Iwanaga S, Farrell DH, Ohtaki S,. Fibrinogen binds to integrin alpha(5)beta(1) via the carboxyl-terminal RGD site of the Aalpha-chain. J Biochem 2000; 128: 705-710.
14. Shachaf Y, Gonen-Wadmany M, Seliktar D,. The biocompatibility of PluronicF127 fibrinogen-based hydrogels. Biomaterials 2010; 31: 2836-2847.
15. King VR, Alovskaya A, Wei DY, Brown RA, Priestley JV,. The use of injectable forms of fibrin and fibronectin to support axonal ingrowth after spinal cord injury. Biomaterials 2010; 31: 4447-4456.
16. Storkebaum E, Lambrechts D, Carmeliet P,. VEGF: Once regarded as a specific angiogenic factor, now implicated in neuroprotection. Bioessays 2004; 26: 943-954.
17. Ruiz, de Almodovar C, Lambrechts D, Mazzone M, Carmeliet P,. Role and therapeutic potential of VEGF in the nervous system. Physiol Rev 2009; 89: 607-648.
18. Carmeliet P, Tessier-Lavigne M,. Common mechanisms of nerve and blood vessel wiring. Nature 2005; 436: 193-200.
19. Sundberg LM, Herrera JJ, Narayana PA,. Effect of vascular endothelial growth factor treatment in experimental traumatic spinal cord injury: In vivo longitudinal assessment. J Neurotrauma 2011; 28: 565-578.
20. van Neerven S, Joosten EA, Brook GA, Lambert CA, Mey J, Weis J, Marcus MA, Steinbusch HW, van Kleef M, Patijn J, Deumens R. Repetitive intrathecal VEGF(165) treatment has limited therapeutic effects after spinal cord injury in the rat. J Neurotrauma 2010; 27: 1781-1791.
21. Golub JS, Kim YT, Duvall CL, Bellamkonda RV, Gupta D, Lin AS, Weiss D, Robert Taylor W, Guldberg RE. Sustained VEGF delivery via PLGA nanoparticles promotes vascular growth. Am J Physiol Heart Circ Physiol 2010; 298: H1959-H1965.
22. Scott RC, Rosano JM, Ivanov Z, Wang B, Chong PL, Issekutz AC, Crabbe DL, Kiani MF. Targeting VEGF-encapsulated immunoliposomes to MI heart improves vascularity and cardiac function. FASEB J 2009.
23. Rocha FG, Sundback CA, Krebs NJ, Leach JK, Mooney DJ, Ashley SW, Vacanti JP, Whang EE. The effect of sustained delivery of vascular endothelial growth factor on angiogenesis in tissue-engineered intestine. Biomaterials 2008; 29: 2884-2890.
24. Huang M, Vitharana SN, Peek LJ, Coop T, Berkland C,. Polyelectrolyte complexes stabilize and controllably release vascular endothelial growth factor. Biomacromolecules 2007; 8: 1607-1614.
25. Formiga FR, Pelacho B, Garbayo E, Abizanda G, Gavira JJ, Simon-Yarza T, Mazo M, Tamayo E, Jauquicoa C, Ortiz-de-Solorzano C, Prosper F, Blanco-Prieto MJ. Sustained release of VEGF through PLGA microparticles improves vasculogenesis and tissue remodeling in an acute myocardial ischemia-reperfusion model. J Control Release 2010; 147: 30-37.
26. des Rieux A, Ucakar B, Mupendwa BP, Colau D, Feron O, Carmeliet P, Preat V. 3D systems delivering VEGF to promote angiogenesis for tissue engineering. J Control Release 2011; 150: 272-278.
27. De Laporte L, Lei Yan A, Shea LD,. Local gene delivery from ECM-coated poly(lactide-co-glycolide) multiple channel bridges after spinal cord injury. Biomaterials 2009; 30: 2361-2368.
28. De Laporte L, Yang Y, Zelivyanskaya ML, Cummings BJ, Anderson AJ, Shea LD,. Plasmid releasing multiple channel bridges for transgene expression after spinal cord injury. Mol Ther 2009; 17: 318-326.
29. Mignion L, Magat J, Schakman O, Marbaix E, Gallez B, Jordan BF,. Hexafluorobenzene in comparison with perfluoro-15-crown-5-ether for repeated monitoring of oxygenation using 19F MRI in a mouse model. Magn Reson Med 2013; 69: 248-254.
30. Johnson PJ, Parker SR, Sakiyama-Elbert SE,. Fibrin-based tissue engineering scaffolds enhance neural fiber sprouting and delay the accumulation of reactive astrocytes at the lesion in a subacute model of spinal cord injury. J Biomed Mater Res A 2010; 92: 152-163.
31. Novikova LN, Mosahebi A, Wiberg M, Terenghi G, Kellerth JO, Novikov LN,. Alginate hydrogel and matrigel as potential cell carriers for neurotransplantation. J Biomed Mater Res A 2006; 77: 242-252.
32. Storkebaum E, Carmeliet P,. VEGF: A critical player in neurodegeneration. J Clin Invest 2004; 113: 14-18.
33. Carmeliet P, Storkebaum E,. Vascular and neuronal effects of VEGF in the nervous system: Implications for neurological disorders. Semin Cell Dev Biol 2002; 13: 39-53.
34. Sondell M, Lundborg G, Kanje M,. Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system. J Neurosci 1999; 19: 5731-5740.
35. Scott R, Marquardt L, Willits RK,. Characterization of poly(ethylene glycol) gels with added collagen for neural tissue engineering. J Biomed Mater Res Part A 2010; 93A: 817-823.
36. Cheng S, Clarke EC, Bilston LE,. Rheological properties of the tissues of the central nervous system: A review. Med Eng Phys 2008; 30: 1318-1337.
37. Veriter S, Mergen J, Goebbels RM, Aouassar N, Gregoire C, Jordan B, Leveque P, Gallez B, Gianello P, Dufrane D. In vivo selection of biocompatible alginates for islet encapsulation and subcutaneous transplantation. Tissue Eng Part A 2010; 16: 1503-1513.
38. Hunt NC, Grover LM,. Cell encapsulation using biopolymer gels for regenerative medicine. Biotechnol Lett 2010; 32: 733-742.
39. Rowley JA, Madlambayan G, Mooney DJ,. Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials 1999; 20: 45-53.
40. Augst AD, Kong HJ, Mooney DJ,. Alginate hydrogels as biomaterials. Macromol Biosci 2006; 6: 623-633.
41. Galateanu B, Dimonie D, Vasile E, Nae S, Cimpean A, Costache M,. Layer-shaped alginate hydrogels enhance the biological performance of human adipose-derived stem cells. BMC Biotechnol 2012; 12: 35.
42. Köllmer M, Keskar V, Hauk TG, Collins JM, Russell B, Gemeinhart RA,. Stem cell-derived extracellular matrix enables survival and multilineage differentiation within superporous hydrogels. Biomacromolecules 2012; 13: 963-973.
43. Lawson MA, Barralet JE, Wang L, Shelton RM, Triffitt JT,. Adhesion and growth of bone marrow stromal cells on modified alginate hydrogels. Tissue Eng 2004; 10: 1480-1491.
44. Macaya D, Spector M,. Injectable hydrogel materials for spinal cord regeneration: A review. Biomed Mater 2012; 7: 012001.
45. Matyash M, Despang F, Mandal R, Fiore D, Gelinsky M, Ikonomidou C,. Novel soft alginate hydrogel strongly supports neurite growth and protects neurons against oxidative stress. Tissue Eng Part A 2012; 18: 55-66.
46. De Laporte L, des Rieux A, Tuinstra HM, Zelivyanskaya ML, De Clerck NM, Postnov AA, Preat V, Shea LD. Vascular endothelial growth factor and fibroblast growth factor 2 delivery from spinal cord bridges to enhance angiogenesis following injury. J Biomed Mater Res A 2011; 98: 372-382.
47. Pereira Lopes FR, Lisboa BC, Frattini F, Almeida FM, Tomaz MA, Matsumoto PK, Langone F, Lora S, Melo PA, Borojevic R, Han SW, Martinez AM. Enhancement of sciatic nerve regeneration after vascular endothelial growth factor (VEGF) gene therapy. Neuropathol Appl Neurobiol 2011; 37: 600-612.
48. Rong W, Wang J, Liu X, Jiang L, Wei F, Hu X, Han X, Liu Z. Naringin treatment improves functional recovery by increasing BDNF and VEGF expression, inhibiting neuronal apoptosis after spinal cord injury. Neurochem Res 2012; 37: 1615-1623.
49. Han X, Yang N, Cui Y, Xu Y, Dang G, Song C,. Simvastatin mobilizes bone marrow stromal cells migrating to injured areas and promotes functional recovery after spinal cord injury in the rat. Neurosci Lett 2012; 521: 136-141.
50. Widenfalk J, Lipson A, Jubran M, Hofstetter C, Ebendal T, Cao Y, Olson L. Vascular endothelial growth factor improves functional outcome and decreases secondary degeneration in experimental spinal cord contusion injury. Neuroscience 2003; 120: 951-960.
51. Hawryluk GW, Mothe A, Wang J, Wang S, Tator C, Fehlings MG,. An in vivo characterization of trophic factor production following neural precursor cell or bone marrow stromal cell transplantation for spinal cord injury. Stem Cells Dev 2012; 21: 2222-2238.
52. Lutton C, Young YW, Williams R, Meedeniya AC, Mackay-Sim A, Goss B,. Combined VEGF and PDGF treatment reduces secondary degeneration after spinal cord injury. J Neurotrauma 2012; 29: 957-970.